Eli Lilly seeks more GPCR weight loss drugs in $1.3bn research deal
The deal follows a similar billion-dollar GPCR partnership made by rival Novo Nordisk earlier this year.
US eosinophilic oesophagitis market to reach $1.19bn by 2030
Eli Lilly accused of bribing providers to prescribe GLP-1RA drugs
Podcast: US tariff news and Q2 earnings influence pharma trends
Insmed wins FDA approval for future blockbuster Brinsupri
Third time lucky as PharmaTher gets FDA approval for ketamine
色界吧
View More
Themes
View MoreFive lessons from biopharma companies鈥� data transformation journeys
A sales rep looking up a healthcare professional's (HCP) contact details finds three records, each with conflicting information. At the same time, leadership struggles to generate accurate global reports due...
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry
GlobalData Reports
View MoreDigital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
AI in drug discovery: from hypothetical to reality
Lisata collaborates with GATC Health on drug development
Juvenescence enhances AI drug discovery with Ro5 acquisition
Pharma鈥檚 AI prospects get nudged into the future with EU鈥檚 AI act聽